Genpact Limited (G) Market Cap & Valuation Ratios
Genpact Limited (G) has a market cap of $6.9B, a trailing P/E of 12.1 and a price-to-sales ratio of 1.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GGenpact LimitedFollow G — free
—
Price chart with a free account
- Market cap
- 6.9B
- P/E TTM
- 12.1
- Dividend yield
- 1.8%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Peers
information technology services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| G | 6.9 | 12.1 | 1.4 | 8.6 | 8.3% | +7% | 15% | 19% |
| QNT | 9.6 | — | — | — | — | — | — | — |
| BZ | 7.7 | — | — | — | — | +12% | 30% | 13% |
| EPAM | 7.0 | 18.5 | 1.1 | 9.1 | 6.9% | +11% | 10% | 15% |
| OTEX | 6.8 | 10.8 | 2.2 | 6.9 | 11.9% | +2% | 21% | 9% |
| EXLS | 6.4 | 26.8 | 2.9 | 16.6 | 4.3% | +14% | 15% | 22% |
| INGM | 6.4 | 15.1 | 0.2 | 7.9 | -3.6% | +12% | 2% | 9% |
| SAIC | 6.1 | 17.0 | 1.1 | 11.3 | 10.1% | -0.8% | 8% | 13% |
| APLD | 5.5 | — | 10.3 | — | — | +167% | -39% | -5% |
| PSN | 5.2 | 33.8 | 1.0 | 14.5 | 5.9% | -6% | 5% | 7% |
| GDS | 4.6 | — | — | — | — | +9% | -0.5% | -0.1% |
| Median of these 10 | 17.8 | 1.1 | 10.2 | 6.4% | +11% | 8% | 9% |
P/E 12.1 vs. a peer median of 17.8; EV/Sales 1.4 vs. 1.1. G's own P/E sits at the 27th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesQNT and BZ and APLD and GDS have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Genpact Limited — questions
- What is Genpact Limited's market cap?
- $6.9B.
- What is Genpact Limited's P/E ratio?
- 12.1 on trailing twelve-month earnings to 2026-06-30.
- What is Genpact Limited's price-to-sales ratio?
- 1.3.
Every figure on this page comes from Genpact Limited's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.